Ayhan Devi̇ren
Research Subjects
Research Interests
Ayhan Devi̇ren has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Rahiye Dilhan Kuru
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Medical Biology, İstanbul, Turkey
3 shared publications - Şükriye Yilmaz
İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Medical Biology, İstanbul, Turkey
3 shared publications - Ayse Cirakoglu
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Trkiye
2 shared publications - Ayse Salihoglu
Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
2 shared publications - Sezen Atasoy
Bezmialem Vakif University
2 shared publications - Yelda Tarkan Argüden
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Trkiye
2 shared publications
Latest Publications
- 28 July 2023
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 15 (2) , 95-101
Conventional and molecular cytogenetic analyses in Behçet’s syndrome patients with gastrointestinal involvement
- 28 July 2023
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 15 (2) , 95-101
Conventional and molecular cytogenetic analyses in Behçet’s syndrome patients with gastrointestinal involvement
- Open Access
- 20 August 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (4) , 453-460
mir210 and BCL2 Expressions in Patients with Acute Myeloid Leukemia
- 20 August 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (4) , 453-460
Open Accessmir210 and BCL2 Expressions in Patients with Acute Myeloid Leukemia
- Open Access
- 29 June 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (3) , 370-375
A Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel
- 29 June 2022
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 10 (3) , 370-375
Open AccessA Preliminary Investigation on the Chromosome Aberrations in Acute Lymphoblastic Leukaemia Using Multiprobe Fluorescence In Situ Hybridization Panel
- Open Access
- 1 March 2022
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 57 (2) , 160-167
Common Polymorphisms of Growth Hormone: Growth Hormone Receptor Axis in Turkish Children with Short Stature
Objective: A single-nucleotide polymorphism of the growth hormone 1 gene, GH1IVS4+90A>T (rs2665802), associated with short stature and a polymorphism of the growth hormone receptor gene, exon 3 deleted variant, associated with increased responsiveness to growth hormone have been reported previously. We aimed to investigate the frequency of both polymorphisms and their correlation to height in Turkish short children. Also, we aimed to evaluate the effect of exon 3 deleted variant on response to 1-year growth hormone therapy. Materials and Methods: Children with idiopathic isolated growth hormone deficiency (n = 39) and with idiopathic short stature (n = 10) and 50 control subjects were evaluated for anthropometric parameters, annual growth velocity, and annual height gain. Growth hormone receptor gene polymorphisms were analyzed via multiplex polymerase chain reaction; growth hormone 1 gene polymorphism was analyzed via polymerase chain reaction and single-strand conformation polymorphism techniques. Results: The frequency of genotypes carrying the “A” allele was not significantly higher in the idiopathic isolated growth hormone deficiency group than in the idiopathic short stature and control groups (P = .03 for each). The exon 3 deleted variant genotype was significantly lower in the idiopathic short stature group compared to the control group (P = .01). There was no effect of exon 3 deleted variant, on response to the first-year growth hormone therapy. Conclusion: In Turkish population, no correlation was found between the “A” allele of GH1IVS4+90A>T polymorphism and idiopathic isolated growth hormone deficiency and short stature, and a significant negative correlation was found between exon 3 deleted variant and idiopathic short stature and short stature. Exon 3 deleted variant has no effect on response to growth hormone treatment. Cite this article as: Yılmaz Güleç E, Ercan O, Erdal Adal S, Buyru AN, Yıldız M, Deviren A. Common polymorphisms of growth hormone – growth hormone receptor axis in Turkish children with short stature. Turk Arch Pediatr. 2022;57(2):160-167.
- 1 March 2022
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 57 (2) , 160-167
Open AccessCommon Polymorphisms of Growth Hormone: Growth Hormone Receptor Axis in Turkish Children with Short Stature
Objective: A single-nucleotide polymorphism of the growth hormone 1 gene, GH1IVS4+90A>T (rs2665802), associated with short stature and a polymorphism of the growth hormone receptor gene, exon 3 deleted variant, associated with increased responsiveness to growth hormone have been reported previously. We aimed to investigate the frequency of both polymorphisms and their correlation to height in Turkish short children. Also, we aimed to evaluate the effect of exon 3 deleted variant on response to 1-year growth hormone therapy. Materials and Methods: Children with idiopathic isolated growth hormone deficiency (n = 39) and with idiopathic short stature (n = 10) and 50 control subjects were evaluated for anthropometric parameters, annual growth velocity, and annual height gain. Growth hormone receptor gene polymorphisms were analyzed via multiplex polymerase chain reaction; growth hormone 1 gene polymorphism was analyzed via polymerase chain reaction and single-strand conformation polymorphism techniques. Results: The frequency of genotypes carrying the “A” allele was not significantly higher in the idiopathic isolated growth hormone deficiency group than in the idiopathic short stature and control groups (P = .03 for each). The exon 3 deleted variant genotype was significantly lower in the idiopathic short stature group compared to the control group (P = .01). There was no effect of exon 3 deleted variant, on response to the first-year growth hormone therapy. Conclusion: In Turkish population, no correlation was found between the “A” allele of GH1IVS4+90A>T polymorphism and idiopathic isolated growth hormone deficiency and short stature, and a significant negative correlation was found between exon 3 deleted variant and idiopathic short stature and short stature. Exon 3 deleted variant has no effect on response to growth hormone treatment. Cite this article as: Yılmaz Güleç E, Ercan O, Erdal Adal S, Buyru AN, Yıldız M, Deviren A. Common polymorphisms of growth hormone – growth hormone receptor axis in Turkish children with short stature. Turk Arch Pediatr. 2022;57(2):160-167.
- 14 May 2019
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 7 (2) , 118-123
Cytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment
- 14 May 2019
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 7 (2) , 118-123
Cytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment